Jyong Biotech MENS
NASDAQ MENS
$1.89 +0.00 (+0.28%)
As of: Oct 22, 2026 · 12:17 PM EDT

Jyong Biotech (MENS) Non-Current Debt (2024 - 2025)

Updated

Jyong Biotech (MENS) posted Non-Current Debt of -$800,000 for the year ended Dec 31, 2025.

Analysis

Jyong Biotech (MENS) Non-Current Debt (2024 - 2025) Analysis & Trends

  • Business Quant data shows MENS's Non-Current Debt at -$120,000 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,168.95 Bn 1,137.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 642.08 Bn 560.60 Bn 17.26 Bn 37.34 Bn
3 AbbVie 500.03 Bn 473.14 Bn 12.70 Bn 62.48 Bn
4 Merck 359.04 Bn 313.42 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.05 Bn 240.74 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.60 Bn 197.00 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 192.44 Bn 166.64 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn 60.50 Bn
10 Jyong Biotech 138.36 Mn 138.36 Mn - 1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Jun 30, 2025 1.95 Mn
Dec 31, 2024 2.03 Mn
API Access

Jyong Biotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MENS&period=max&api_key=YOUR_API_KEY